109 related articles for article (PubMed ID: 3611532)
1. Zinc absorption from glucose and amino acid dialysis solutions in children on continuous ambulatory peritoneal dialysis (CAPD).
Zlotkin SH; Rundle MA; Hanning RM; Buchanan BE; Balfe JW
J Am Coll Nutr; 1987 Aug; 6(4):345-50. PubMed ID: 3611532
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and nutritional consequences of amino acid-based vs glucose-based dialysis solutions in infants and children receiving CAPD.
Hanning RM; Balfe JW; Zlotkin SH
Am J Clin Nutr; 1987 Jul; 46(1):22-30. PubMed ID: 3300250
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding.
Tjiong HL; Rietveld T; Wattimena JL; van den Berg JW; Kahriman D; van der Steen J; Hop WC; Swart R; Fieren MW
Clin J Am Soc Nephrol; 2007 Jan; 2(1):74-80. PubMed ID: 17699390
[TBL] [Abstract][Full Text] [Related]
4. A quantitative description of solute and fluid transport during peritoneal dialysis.
Heimbürger O; Waniewski J; Werynski A; Lindholm B
Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
[TBL] [Abstract][Full Text] [Related]
5. Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solutions: technical and metabolic aspects.
Canepa A; Perfumo F; Carrea A; Piccardo MT; Ciardi MR; Cantaluppi A; Gusmano R
Perit Dial Int; 1990; 10(3):215-20. PubMed ID: 2094461
[TBL] [Abstract][Full Text] [Related]
6. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
Maurer O; Saxenhofer H; Jaeger P; Casez JP; Descoeudres C; Horber FF
Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
[TBL] [Abstract][Full Text] [Related]
7. Effect of amino acid containing dialysis solutions on plasma amino acid profiles in children with chronic renal failure.
Hanning RM; Balfe JW; Zlotkin SH
J Pediatr Gastroenterol Nutr; 1987; 6(6):942-7. PubMed ID: 3681581
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
Kim DH; Yang DH; Hong SY
Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of short-chain polypeptides as an osmotic agent in continuous ambulatory peritoneal dialysis patients.
Imholz AL; Lameire N; Faict D; Koomen GC; Krediet RT; Martis L
Perit Dial Int; 1994; 14(3):215-22. PubMed ID: 7948230
[TBL] [Abstract][Full Text] [Related]
11. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
12. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
13. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.
Canepa A; Carrea A; Menoni S; Verrina E; Trivelli A; Gusmano R; Perfumo F
Kidney Int; 2001 May; 59(5):1967-73. PubMed ID: 11318970
[TBL] [Abstract][Full Text] [Related]
15. Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients--no effect on nutritional status.
Dombros NV; Prutis K; Tong M; Anderson GH; Harrison J; Sombolos K; Digenis G; Pettit J; Oreopoulos DG
Perit Dial Int; 1990; 10(1):79-84. PubMed ID: 2085588
[TBL] [Abstract][Full Text] [Related]
16. Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Kluthe R; Baumann G; Schollmeyer P
Am J Nephrol; 1992; 12(1-2):61-7. PubMed ID: 1415367
[TBL] [Abstract][Full Text] [Related]
17. Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis.
Qamar IU; Levin L; Balfe JW; Balfe JA; Secker D; Zlotkin S
Perit Dial Int; 1994; 14(1):34-41. PubMed ID: 8312411
[TBL] [Abstract][Full Text] [Related]
18. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
[TBL] [Abstract][Full Text] [Related]
19. Amino-acid-based continuous ambulatory peritoneal dialysis (CAPD) fluid over twelve weeks: effects on carbohydrate and lipid metabolism.
Dibble JB; Young GA; Hobson SM; Brownjohn AM
Perit Dial Int; 1990; 10(1):71-7. PubMed ID: 2085587
[TBL] [Abstract][Full Text] [Related]
20. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
